Related news for:
Mater people have made an outstanding impression at the annual University of Queensland Faculty of Medicine Excellence Awards.
In the recent NHMRC Ideas and Investigator Grant rounds, Mater Research was successful in obtaining funding for five research grants totaling $6.6 million.
Dr Joshua Tobin a haematologist-in-training at Mater has been awarded the prestigious 2019 Celgene Future Leaders in Hematology Award in Orlando, Florida on Saturday 7 December.
Professor Brian Gabrielli and team seek out the to answer a question—what is broken in melanomas that allows the damage to accumulate rather than repair, leading to mutations?
Mater Hospital is leading the way in cutting-edge health and medical research at the Research Australia Awards.
Collaboration between clinical research institutes the Griffith Institute for Drug Discovery, Mater Research and Translational Research Institute has led to a breakthrough in cancer research.
The Annual Mater Research Awards and Young Investigator Symposium has been held in Brisbane this week recognising the significant contribution of seasoned and emerging Mater researcher talent.
Mater Researcher Dr Felicity Davis has been awarded one of two $50,000 Metcalf Prizes from the National Stem Cell Foundation of Australia.
A new spin-out from The University of Queensland will develop a novel therapy for the growing problem of obesity-related liver disease with the support of an initial investment from IP Group.
Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.
Mater researcher Dr Vicki Clifton and Mater Centre for Neuroscience’s Dr Lisa Gillinder have been recognised for their achievements at the 22nd annual Women in Technology (WiT) Awards.
Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with follicular lymphoma.